Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.

Scialla JJ, Parekh RS, Eustace JA, Astor BC, Plantinga L, Jaar BG, Shafi T, Coresh J, Powe NR, Melamed ML.

Am J Nephrol. 2015 Aug 20;42(1):25-34. [Epub ahead of print]

PMID:
26287973
2.

A finger photoplethysmography waveform during the valsalva maneuver detects changes in left heart filling pressure after hemodialysis.

Galiatsatos P, Parakh K, Monti J, Thavarajah S, Aneke-Ogbu H, Watson A, Kim D, Wang NY, Shafi T, Silber HA.

BMC Nephrol. 2015 Aug 14;16:138. doi: 10.1186/s12882-015-0135-0.

3.
4.

Plasma Iohexol Clearance for Assessing Residual Kidney Function in Dialysis Patients.

Shafi T, Levey AS, Inker LA, Schwartz GJ, Knight C, Abraham AG, Eckfeldt JH, Coresh J.

Am J Kidney Dis. 2015 Jul 21. pii: S0272-6386(15)00864-1. doi: 10.1053/j.ajkd.2015.06.010. [Epub ahead of print] No abstract available.

PMID:
26209541
5.

The effects of weight change on glomerular filtration rate.

Chang A, Greene TH, Wang X, Kendrick C, Kramer H, Wright J, Astor B, Shafi T, Toto R, Lewis J, Appel LJ, Grams M.

Nephrol Dial Transplant. 2015 Jun 17. pii: gfv219. [Epub ahead of print]

PMID:
26085555
6.

Renal Handling of β-Trace Protein: Interpreting the Evidence.

Shafi T, Pluznick JL.

Am J Kidney Dis. 2015 Jun;65(6):967. doi: 10.1053/j.ajkd.2015.01.033. No abstract available.

PMID:
26003611
7.

Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators.

Shafi T, Meyer TW, Hostetter TH, Melamed ML, Parekh RS, Hwang S, Banerjee T, Coresh J, Powe NR.

PLoS One. 2015 May 4;10(5):e0126048. doi: 10.1371/journal.pone.0126048. eCollection 2015.

8.

Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study.

Parekh RS, Meoni LA, Jaar BG, Sozio SM, Shafi T, Tomaselli GF, Lima JA, Tereshchenko LG, Estrella MM, Kao WH.

BMC Nephrol. 2015 Apr 24;16:63. doi: 10.1186/s12882-015-0050-4.

9.

Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study.

Tangri N, Miskulin DC, Zhou J, Bandeen-Roche K, Michels WM, Ephraim PL, McDermott A, Crews DC, Scialla JJ, Sozio SM, Shafi T, Jaar BG, Meyer K, Ebony Boulware L; DEcIDE Network Patient Outcomes in End-Stage Renal Disease Study Investigators.

Nephrol Dial Transplant. 2015 Apr;30(4):667-75. doi: 10.1093/ndt/gfu349. Epub 2014 Nov 2.

PMID:
25366328
10.

Intravenous iron exposure and mortality in patients on hemodialysis.

Miskulin DC, Tangri N, Bandeen-Roche K, Zhou J, McDermott A, Meyer KB, Ephraim PL, Michels WM, Jaar BG, Crews DC, Scialla JJ, Sozio SM, Shafi T, Wu AW, Cook C, Boulware LE; Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1930-9. doi: 10.2215/CJN.03370414. Epub 2014 Oct 15.

PMID:
25318751
11.

Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Banerjee T, Kim SJ, Astor B, Shafi T, Coresh J, Powe NR.

Am J Kidney Dis. 2014 Dec;64(6):954-61. doi: 10.1053/j.ajkd.2014.07.010. Epub 2014 Sep 27.

PMID:
25266479
12.

Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) study.

Jaar BG, Zhang L, Chembrovich SV, Sozio SM, Shafi T, Scialla JJ, Tomaselli GF, Lima JA, Kao WH, Parekh RS, Meoni LA.

BMC Nephrol. 2014 May 1;15:68. doi: 10.1186/1471-2369-15-68.

13.

Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.

Shafi T, Zager PG, Sozio SM, Grams ME, Jaar BG, Christenson RH, Boulware LE, Parekh RS, Powe NR, Coresh J.

Am J Kidney Dis. 2014 Sep;64(3):443-51. doi: 10.1053/j.ajkd.2014.03.015. Epub 2014 Apr 29.

14.

An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States.

Scialla JJ, Liu J, Crews DC, Guo H, Bandeen-Roche K, Ephraim PL, Tangri N, Sozio SM, Shafi T, Miskulin DC, Michels WM, Jaar BG, Wu AW, Powe NR, Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Kidney Int. 2014 Oct;86(4):798-809. doi: 10.1038/ki.2014.110. Epub 2014 Apr 30.

15.

Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD.

Crews DC, Scialla JJ, Boulware LE, Navaneethan SD, Nally JV Jr, Liu X, Arrigain S, Schold JD, Ephraim PL, Jolly SE, Sozio SM, Michels WM, Miskulin DC, Tangri N, Shafi T, Wu AW, Bandeen-Roche K; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Am J Kidney Dis. 2014 May;63(5):806-15. doi: 10.1053/j.ajkd.2013.12.010. Epub 2014 Feb 6.

16.

Hypertension in hemodialysis patients: an opinion-based update.

Shafi T, Waheed S, Zager PG.

Semin Dial. 2014 Mar;27(2):146-53. doi: 10.1111/sdi.12195. Epub 2014 Feb 5. Review.

17.

Biomarkers of vascular calcification and mortality in patients with ESRD.

Scialla JJ, Kao WH, Crainiceanu C, Sozio SM, Oberai PC, Shafi T, Coresh J, Powe NR, Plantinga LC, Jaar BG, Parekh RS.

Clin J Am Soc Nephrol. 2014 Apr;9(4):745-55. doi: 10.2215/CJN.05450513. Epub 2014 Jan 23.

18.

Predialysis systolic BP variability and outcomes in hemodialysis patients.

Shafi T, Sozio SM, Bandeen-Roche KJ, Ephraim PL, Luly JR, St Peter WL, McDermott A, Scialla JJ, Crews DC, Tangri N, Miskulin DC, Michels WM, Jaar BG, Herzog CA, Zager PG, Meyer KB, Wu AW, Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

J Am Soc Nephrol. 2014 Apr;25(4):799-809. doi: 10.1681/ASN.2013060667. Epub 2014 Jan 2.

19.

Trends in anemia management in US hemodialysis patients 2004-2010.

Miskulin DC, Zhou J, Tangri N, Bandeen-Roche K, Cook C, Ephraim PL, Crews DC, Scialla JJ, Sozio SM, Shafi T, Jaar BG, Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

BMC Nephrol. 2013 Dec 1;14:264. doi: 10.1186/1471-2369-14-264.

20.

Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months.

St Peter WL, Sozio SM, Shafi T, Ephraim PL, Luly J, McDermott A, Bandeen-Roche K, Meyer KB, Crews DC, Scialla JJ, Miskulin DC, Tangri N, Jaar BG, Michels WM, Wu AW, Boulware LE; DEcIDE Network Patient Outcomes in End-Stage Renal Disease Study Investigators.

BMC Nephrol. 2013 Nov 12;14:249. doi: 10.1186/1471-2369-14-249.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk